{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:21:41Z","timestamp":1791418901648,"version":"4.3.3"},"reference-count":50,"publisher":"American Association for Cancer Research (AACR)","issue":"4","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,2,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Severe ascites is a hallmark of advanced ovarian cancer (OVCA), yet the underlying mechanism that creates an imbalance between peritoneal vascular leakage and lymphatic drainage is unknown. Here, we identified and characterized peritoneal lymphatic vessels in OVCA mice, a model generated by implantation of human OVCA cells into athymic nude mice. The OVCA mice displayed substantial lymphangiogenesis and lymphatic remodeling, massive infiltration of CD11b+\/LYVE-1+ macrophages and disseminated carcinomatosis in the mesentery and diaphragm, and progressive chylous ascites formation. Functional assays indicated that the abnormally abundant lymphatic vessels in the diaphragm were not conductive in peritoneal fluid drainage. Moreover, lipid absorbed from the gut leaked out from the aberrant mesenteric lymphatic vessels. Our results indicate that vascular endothelial growth factor (VEGF)-C, VEGF-D, and VEGF-A from CD11b+ macrophages are responsible for producing OVCA-induced dysfunctional lymphangiogenesis, although other cell types contribute to the increased ascites formation. Accordingly, the combined blockade of VEGF-C\/D and VEGF-A signaling with soluble VEGF receptor-3 and VEGF-Trap, respectively, markedly inhibited chylous ascites formation. These findings provide additional therapeutic targets to ameliorate chylous ascites formation in patients with advanced OVCA. [Cancer Res 2008;68(4):1100\u20139]<\/jats:p>","DOI":"10.1158\/0008-5472.can-07-2572","type":"journal-article","created":{"date-parts":[[2008,2,15]],"date-time":"2008-02-15T14:07:20Z","timestamp":1203084440000},"page":"1100-1109","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":101,"title":["Profound but Dysfunctional Lymphangiogenesis via Vascular Endothelial Growth Factor Ligands from CD11b+ Macrophages in Advanced Ovarian Cancer"],"prefix":"10.1158","volume":"68","author":[{"given":"Bong-Hyun","family":"Jeon","sequence":"first","affiliation":[{"name":"1National Research Laboratory of Vascular Biology and Biomedical Research Center, Department of Biological Sciences, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cholsoon","family":"Jang","sequence":"additional","affiliation":[{"name":"1National Research Laboratory of Vascular Biology and Biomedical Research Center, Department of Biological Sciences, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinah","family":"Han","sequence":"additional","affiliation":[{"name":"1National Research Laboratory of Vascular Biology and Biomedical Research Center, Department of Biological Sciences, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghu P.","family":"Kataru","sequence":"additional","affiliation":[{"name":"1National Research Laboratory of Vascular Biology and Biomedical Research Center, Department of Biological Sciences, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianhua","family":"Piao","sequence":"additional","affiliation":[{"name":"1National Research Laboratory of Vascular Biology and Biomedical Research Center, Department of Biological Sciences, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keehoon","family":"Jung","sequence":"additional","affiliation":[{"name":"1National Research Laboratory of Vascular Biology and Biomedical Research Center, Department of Biological Sciences, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Ji","family":"Cha","sequence":"additional","affiliation":[{"name":"1National Research Laboratory of Vascular Biology and Biomedical Research Center, Department of Biological Sciences, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reto A.","family":"Schwendener","sequence":"additional","affiliation":[{"name":"2Laboratory of Liposome Research, Institute of Molecular Cancer Research, University of Zurich, Zurich, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyu Yun","family":"Jang","sequence":"additional","affiliation":[{"name":"3Department of Pathology and Obstetrics and Gynecology, Chonbuk University Medical School, Jeonju, Republic of Korea; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwan-Sik","family":"Kim","sequence":"additional","affiliation":[{"name":"3Department of Pathology and Obstetrics and Gynecology, Chonbuk University Medical School, Jeonju, Republic of Korea; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari","family":"Alitalo","sequence":"additional","affiliation":[{"name":"4The Molecular\/Cancer Biology Laboratory, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gou Young","family":"Koh","sequence":"additional","affiliation":[{"name":"1National Research Laboratory of Vascular Biology and Biomedical Research Center, Department of Biological Sciences, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2008,2,15]]},"reference":[{"key":"2022061700280110600_B1","doi-asserted-by":"crossref","unstructured":"Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics 2007. CA Cancer J Clin\u20082007; 57: 43\u201366.","DOI":"10.3322\/canjclin.57.1.43"},{"key":"2022061700280110600_B2","doi-asserted-by":"crossref","unstructured":"Colombo N, Van GT, Parma G, et al. Ovarian cancer. Crit Rev Oncol Hematol\u20082006; 60: 159\u201379.","DOI":"10.1016\/j.critrevonc.2006.03.004"},{"key":"2022061700280110600_B3","doi-asserted-by":"crossref","unstructured":"Aalami OO, Allen DB, Organ CH. Chylous ascites: a collective review. Surgery\u20082000; 128: 761\u201378.","DOI":"10.1067\/msy.2000.109502"},{"key":"2022061700280110600_B4","doi-asserted-by":"crossref","unstructured":"Boran N, Cil AP, Tulunay G, Ozgul N, Kose MF. Chylous ascites following para-aortic lymphadenectomy: a case report. Gynecol Oncol\u20082004; 93: 711\u20134.","DOI":"10.1016\/j.ygyno.2004.03.022"},{"key":"2022061700280110600_B5","doi-asserted-by":"crossref","unstructured":"Wright JD, Hagemann A, Rader JS, et al. Bevacizumab combination therapy in recurrent, platinum-refractory, epithelial ovarian carcinoma: a retrospective analysis. Cancer\u20082006; 107: 83\u20139.","DOI":"10.1002\/cncr.21969"},{"key":"2022061700280110600_B6","unstructured":"Luo JC, Yamaguchi S, Shinkai A, Shitara K, Shibuya M. Significant expression of vascular endothelial growth factor\/vascular permeability factor in mouse ascites tumors. Cancer Res\u20081998; 58: 2652\u201360."},{"key":"2022061700280110600_B7","unstructured":"Nagy JA, Masse EM, Herzberg KT, et al. Pathogenesis of ascites tumor growth: vascular permeability factor, vascular hyperpermeability, and ascites fluid accumulation. Cancer Res\u20081995; 55: 360\u20138."},{"key":"2022061700280110600_B8","unstructured":"Nagy JA, Morgan ES, Herzberg KT, Manseau EJ, Dvorak AM, Dvorak HF. Pathogenesis of ascites tumor growth: angiogenesis, vascular remodeling, and stroma formation in the peritoneal lining. Cancer Res\u20081995; 55: 376\u201385."},{"key":"2022061700280110600_B9","unstructured":"Byrne AT, Ross L, Holash J, et al. Vascular endothelial growth factor-trap decreases tumor burden, inhibits ascites, and causes dramatic vascular remodeling in an ovarian cancer model. Clin Cancer Res\u20082003; 9: 5721\u20138."},{"key":"2022061700280110600_B10","doi-asserted-by":"crossref","unstructured":"Hu L, Hofmann J, Holash J, Yancopoulos GD, Sood AK, Jaffe RB. Vascular endothelial growth factor trap combined with paclitaxel strikingly inhibits tumor and ascites, prolonging survival in a human ovarian cancer model. Clin Cancer Res\u20082005; 11: 6966\u201371.","DOI":"10.1158\/1078-0432.CCR-05-0910"},{"key":"2022061700280110600_B11","doi-asserted-by":"crossref","unstructured":"Mesiano S, Ferrara N, Jaffe RB. Role of vascular endothelial growth factor in ovarian cancer: inhibition of ascites formation by immunoneutralization. Am J Pathol\u20081998; 153: 1249\u201356.","DOI":"10.1016\/S0002-9440(10)65669-6"},{"key":"2022061700280110600_B12","doi-asserted-by":"crossref","unstructured":"Monk BJ, Han E, Josephs-Cowan CA, Pugmire G, Burger RA. Salvage bevacizumab (rhuMAB VEGF)-based therapy after multiple prior cytotoxic regimens in advanced refractory epithelial ovarian cancer. Gynecol Oncol\u20082006; 102: 140\u20134.","DOI":"10.1016\/j.ygyno.2006.05.006"},{"key":"2022061700280110600_B13","unstructured":"Feldman GB, Knapp RC, Order SE, Hellman S. The role of lymphatic obstruction in the formation of ascites in a murine ovarian carcinoma. Cancer Res\u20081972; 32: 1663\u20136."},{"key":"2022061700280110600_B14","doi-asserted-by":"crossref","unstructured":"Ji RC. Lymphatic endothelial cells, lymphangiogenesis, and extracellular matrix. Lymphat Res Biol\u20082006; 4: 83\u2013100.","DOI":"10.1089\/lrb.2006.4.83"},{"key":"2022061700280110600_B15","doi-asserted-by":"crossref","unstructured":"Pepper MS, Skobe M. Lymphatic endothelium: morphological, molecular and functional properties. J Cell Biol\u20082003; 163: 209\u201313.","DOI":"10.1083\/jcb.200308082"},{"key":"2022061700280110600_B16","doi-asserted-by":"crossref","unstructured":"von Andrian UH, Mempel TR. Homing and cellular traffic in lymph nodes. Nat Rev Immunol\u20082003; 3: 867\u20138.","DOI":"10.1038\/nri1222"},{"key":"2022061700280110600_B17","unstructured":"Saladin KS. Anatomy & physiology: the unity of form and function. In: The lymphatic and immune system. Boston (MA): McGraw Hill; 2004. p.799\u2013835."},{"key":"2022061700280110600_B18","doi-asserted-by":"crossref","unstructured":"Tsilibary EC, Wissig SL. Light and electron microscope observations of the lymphatic drainage units of the peritoneal cavity of rodents. Am J Anat\u20081987; 180: 195\u2013207.","DOI":"10.1002\/aja.1001800209"},{"key":"2022061700280110600_B19","doi-asserted-by":"crossref","unstructured":"Azzali G. The lymphatic vessels and the so-called \u201clymphatic stomata\u201d of the diaphragm: a morphologic ultrastructural and three-dimensional study. Microvasc Res\u20081999; 57: 30\u201343.","DOI":"10.1006\/mvre.1998.2101"},{"key":"2022061700280110600_B20","doi-asserted-by":"crossref","unstructured":"Shinohara H. Lymphatic system of the mouse diaphragm: morphology and function of the lymphatic sieve. Anat Rec\u20081997; 249: 6\u201315.","DOI":"10.1002\/(SICI)1097-0185(199709)249:1<6::AID-AR2>3.0.CO;2-P"},{"key":"2022061700280110600_B21","doi-asserted-by":"crossref","unstructured":"Hong YK, Shin JW, Detmar M. Development of the lymphatic vascular system: a mystery unravels. Dev Dyn\u20082004; 231: 462\u201373.","DOI":"10.1002\/dvdy.20179"},{"key":"2022061700280110600_B22","doi-asserted-by":"crossref","unstructured":"Alitalo K, Tammela T, Petrova TV. Lymphangiogenesis in development and human disease. Nature\u20082005; 438: 946\u201353.","DOI":"10.1038\/nature04480"},{"key":"2022061700280110600_B23","doi-asserted-by":"crossref","unstructured":"Oliver G, Alitalo K. The lymphatic vasculature: recent progress and paradigms. Annu Rev Cell Dev Biol\u20082005; 21: 457\u201383.","DOI":"10.1146\/annurev.cellbio.21.012704.132338"},{"key":"2022061700280110600_B24","doi-asserted-by":"crossref","unstructured":"He Y, Karpanen T, Alitalo K. Role of lymphangiogenic factors in tumor metastasis. Biochim Biophys Acta\u20082004; 1654: 3\u201312.","DOI":"10.1016\/j.bbcan.2003.07.003"},{"key":"2022061700280110600_B25","doi-asserted-by":"crossref","unstructured":"Tobler NE, Detmar M. Tumor and lymph node lymphangiogenesis\u2014impact on cancer metastasis. J Leukoc Biol\u20082006; 80: 691\u20136.","DOI":"10.1189\/jlb.1105653"},{"key":"2022061700280110600_B26","doi-asserted-by":"crossref","unstructured":"Baluk P, Tammela T, Ator E, et al. Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. J Clin Invest\u20082005; 115: 247\u201357.","DOI":"10.1172\/JCI200522037"},{"key":"2022061700280110600_B27","doi-asserted-by":"crossref","unstructured":"Maruyama K, Ii M, Cursiefen C, et al. Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages. J Clin Invest\u20082005; 115: 2363\u201372.","DOI":"10.1172\/JCI23874"},{"key":"2022061700280110600_B28","doi-asserted-by":"crossref","unstructured":"Cursiefen C, Chen L, Borges LP, et al. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J Clin Invest\u20082004; 113: 1040\u201350.","DOI":"10.1172\/JCI20465"},{"key":"2022061700280110600_B29","doi-asserted-by":"crossref","unstructured":"Kerjaschki D. The crucial role of macrophages in lymphangiogenesis. J Clin Invest\u20082005; 115: 2316\u20139.","DOI":"10.1172\/JCI26354"},{"key":"2022061700280110600_B30","doi-asserted-by":"crossref","unstructured":"Schoppmann SF, Birner P, Stockl J, et al. Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am J Pathol\u20082002; 161: 947\u201356.","DOI":"10.1016\/S0002-9440(10)64255-1"},{"key":"2022061700280110600_B31","doi-asserted-by":"crossref","unstructured":"Nilsson MB, Langley RR, Fidler IJ. Interleukin-6, secreted by human ovarian carcinoma cells, is a potent proangiogenic cytokine. Cancer Res\u20082005; 65: 10794\u2013800.","DOI":"10.1158\/0008-5472.CAN-05-0623"},{"key":"2022061700280110600_B32","doi-asserted-by":"crossref","unstructured":"Szlosarek PW, Grimshaw MJ, Kulbe H, et al. Expression and regulation of tumor necrosis factor \u03b1 in normal and malignant ovarian epithelium. Mol Cancer Ther\u20082006; 5: 382\u201390.","DOI":"10.1158\/1535-7163.MCT-05-0303"},{"key":"2022061700280110600_B33","doi-asserted-by":"crossref","unstructured":"Holash J, Davis S, Papadopoulos N, et al. VEGF-Trap: a VEGF blocker with potent antitumor effects. Proc Natl Acad Sci U S A\u20082002; 99: 11393\u20138.","DOI":"10.1073\/pnas.172398299"},{"key":"2022061700280110600_B34","doi-asserted-by":"crossref","unstructured":"Makinen T, Jussila L, Veikkola T, et al. Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. Nat Med\u20082001; 7: 199\u2013205.","DOI":"10.1038\/84651"},{"key":"2022061700280110600_B35","doi-asserted-by":"crossref","unstructured":"Zeisberger SM, Odermatt B, Marty C, Zehnder-Fjallman AH, Ballmer-Hofer K, Schwendener RA. Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach. Br J Cancer\u20082006; 95: 272\u201381.","DOI":"10.1038\/sj.bjc.6603240"},{"key":"2022061700280110600_B36","doi-asserted-by":"crossref","unstructured":"Seiler P, Aichele P, Odermatt B, Hengartner H, Zinkernagel RM, Schwendener RA. Crucial role of marginal zone macrophages and marginal zone metallophils in the clearance of lymphocytic choriomeningitis virus infection. Eur J Immunol\u20081997; 27: 2626\u201333.","DOI":"10.1002\/eji.1830271023"},{"key":"2022061700280110600_B37","doi-asserted-by":"crossref","unstructured":"Banerji S, Ni J, Wang SX, et al. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol\u20081999; 144: 789\u2013801.","DOI":"10.1083\/jcb.144.4.789"},{"key":"2022061700280110600_B38","doi-asserted-by":"crossref","unstructured":"Cho CH, Koh YJ, Han J, et al. Angiogenic role of LYVE-1-positive macrophages in adipose tissue. Circ Res\u20082007; 100: 47\u201357.","DOI":"10.1161\/01.RES.0000259564.92792.93"},{"key":"2022061700280110600_B39","doi-asserted-by":"crossref","unstructured":"Wigle JT, Oliver G. Prox1 function is required for the development of the murine lymphatic system. Cell\u20081999; 98: 769\u201378.","DOI":"10.1016\/S0092-8674(00)81511-1"},{"key":"2022061700280110600_B40","doi-asserted-by":"crossref","unstructured":"Gerhardt H, Golding M, Fruttiger M, et al. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol\u20082003; 161: 1163\u201377.","DOI":"10.1083\/jcb.200302047"},{"key":"2022061700280110600_B41","doi-asserted-by":"crossref","unstructured":"Valtola R, Salven P, Heikkila\u0308 P, et al. VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer. Am J Pathol\u20081999; 154: 1381\u201390.","DOI":"10.1016\/S0002-9440(10)65392-8"},{"key":"2022061700280110600_B42","doi-asserted-by":"crossref","unstructured":"Kubo H, Fujiwara T, Jussila L, et al. Involvement of vascular endothelial growth factor receptor-3 in maintenance of integrity of endothelial cell lining during tumor angiogenesis. Blood\u20082000; 96: 546\u201353.","DOI":"10.1182\/blood.V96.2.546.014k12_546_553"},{"key":"2022061700280110600_B43","doi-asserted-by":"crossref","unstructured":"Kaipainen A, Korhonen J, Mustonen T, et al. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci U S A\u20081995; 92: 3566\u201370.","DOI":"10.1073\/pnas.92.8.3566"},{"key":"2022061700280110600_B44","doi-asserted-by":"crossref","unstructured":"Abernethy NJ, Chin W, Hay JB, Rodela H, Oreopoulos D, Johnston MG. Lymphatic drainage of the peritoneal cavity in sheep. Am J Physiol\u20081991; 260: 353\u20138.","DOI":"10.1152\/ajprenal.1991.260.3.F353"},{"key":"2022061700280110600_B45","doi-asserted-by":"crossref","unstructured":"Shibata SJ, Hiramatsu Y, Kaseda M, et al. The time course of lymph drainage from the peritoneal cavity in beagle dogs. J Vet Med Sci\u20082006; 68: 1143\u20137.","DOI":"10.1292\/jvms.68.1143"},{"key":"2022061700280110600_B46","doi-asserted-by":"crossref","unstructured":"Hwang SJ, Choi HH, Kim KT, Hong HJ, Koh GY, Lee GM. Expression and purification of recombinant human angiopoietin-2 produced in Chinese hamster ovary cells. Protein Expr Purif\u20082005; 39: 175\u201383.","DOI":"10.1016\/j.pep.2004.09.005"},{"key":"2022061700280110600_B47","doi-asserted-by":"crossref","unstructured":"Cao Y. Opinion: emerging mechanisms of tumour lymphangiogenesis and lymphatic metastasis. Nat Rev Cancer\u20082005; 5: 735\u201343.","DOI":"10.1038\/nrc1693"},{"key":"2022061700280110600_B48","doi-asserted-by":"crossref","unstructured":"Cueni LN, Detmar M. New insights into the molecular control of the lymphatic vascular system and its role in disease. J Invest Dermatol\u20082006; 126: 2167\u201377.","DOI":"10.1038\/sj.jid.5700464"},{"key":"2022061700280110600_B49","doi-asserted-by":"crossref","unstructured":"Joukov V, Sorsa T, Kumar V, et al. Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J\u20081997; 16: 3898\u2013911.","DOI":"10.1093\/emboj\/16.13.3898"},{"key":"2022061700280110600_B50","doi-asserted-by":"crossref","unstructured":"Achen MG, Jeltsch M, Kukk E, et al. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc Natl Acad Sci U S A\u20081998; 95: 548\u201353.","DOI":"10.1073\/pnas.95.2.548"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/68\/4\/1100\/2599231\/1100.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/68\/4\/1100\/2599231\/1100.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T01:02:05Z","timestamp":1655427725000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/68\/4\/1100\/541831\/Profound-but-Dysfunctional-Lymphangiogenesis-via"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2,15]]},"references-count":50,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2008,2,15]]},"published-print":{"date-parts":[[2008,2,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-07-2572","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.22373898","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22373898.v1","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6497247","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6497247.v1","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2,15]]}}}